Research Article

Impedimetric CRISPR-dCas9 Based Biosensor System for Sickle Cell Anemia Mutation

Volume: 9 Number: 3 August 31, 2022
EN

Impedimetric CRISPR-dCas9 Based Biosensor System for Sickle Cell Anemia Mutation

Abstract

Sickle cell anemia is one of the single point mutation diseases with symptoms such as stroke, lethargy, chronic anemia, and increased mortality, and it causes red blood cells to become sickle-shaped. In the study, a biosensor system was developed to detect this mutation quickly and cost-effectively. This biosensor system was prepared by forming a SAM layer with 4-Aminothiophenol (4-ATP) on the gold electrode, and coating it with amino graphene. It was then modified with SG-RNA with the sequence of the target mutation after CRISPR-dCas9 immobilization. The nanomaterial used in the preparation of the biosensor increased the sensitivity of the method by increasing the surface area. The biosensor prepared in this way was optimized and made to perform DNA analysis. As a measurement method, electrochemical impedance spectroscopy (EIS) was used. Electrochemical measurements were carried out in 50 mM pH 7.0 phosphate buffer solution, which includes 5 mM Fe(CN)64- /3- and 10 mM KCl, as redox probe solution by CV and EIS in this redox probe solution. EIS parameters were 10,000–0.05 Hz frequency, 10 mV AC and 180 mV DC potentials, and CV parameters were between - 0.2 to 0.5 V potential, 100 mV/s scan rate for 5 cycles. The DNA measurement time of the biosensor system was determined by the chronoimpedance measurements taken by applying a frequency of 500 Hz under 200 mV DC current. Measurement time of the biosensor was found to be 100 seconds. With the CRISPR-Cas9 based electrochemical biosensor system, which gives faster results compared to the measurement methods in the literature, a linear measurement between 40 pM and 1000 pM with a length of 400 base pairs was taken.

Keywords

Thanks

The author want to thank Center for Fabrication and Applications of Electronic Materials at Dokuz Eylul University where characterization measurements were performed.

References

  1. 1. Breveglieri G, D’Aversa E, Cosenza LC, Boutou E, Balassopoulou A, Voskaridou E, et al. Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor. Sensors and Actuators B: Chemical. 2019 Oct;296:126604.
  2. 2. Kasiri M, Rahaie M. A visible and colorimetric nanobiosensor based on DNA-CuO nanoparticle for detection of single nucleotide polymorphism involved in sickle cell anemia disease. Materials Today Communications. 2021 Jun;27:102423.
  3. 3. Sahu M, Biswas AK, Uma K. Detection of Sickle Cell Anemia in Red Blood Cell. A International Journal of Engineering and Applied Sciences (IJEAS). 2015;2(3).
  4. 4. Brazaca LC, Bramorski CB, Cancino-Bernardi J, Janegitz BC, Zucolotto V. A Genosensor for Sickle Cell Anemia Trait Determination. Electroanalysis. 2017 Mar;29(3):773–7.
  5. 5. Barrett AN, McDonnell TCR, Chan KCA, Chitty LS. Digital PCR Analysis of Maternal Plasma for Noninvasive Detection of Sickle Cell Anemia. Clinical Chemistry. 2012 Jun 1;58(6):1026–32.
  6. 6. Galvão AF, Petta T, Flamand N, Bollela VR, Silva CL, Jarduli LR, et al. Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment. Analytical and Bioanalytical Chemistry. 2016 May;408(13):3613–23.
  7. 7. Ali TH, Alamiry AAN, Majeed MN. Detection of hemoglobinopathies in hypochromic, microcytic and sickeled cell blood films by hemoglobin electrophoresis. University of Thi-Qar Journal Of Medicine. 2011;5(1):139–48.
  8. 8. Tothill IE. Biosensors for cancer markers diagnosis. Seminars in Cell & Developmental Biology. 2009 Feb;20(1):55–62.

Details

Primary Language

English

Subjects

Chemical Engineering

Journal Section

Research Article

Publication Date

August 31, 2022

Submission Date

December 6, 2021

Acceptance Date

March 31, 2022

Published in Issue

Year 2022 Volume: 9 Number: 3

APA
Ertuğrul Uygun, H. D. (2022). Impedimetric CRISPR-dCas9 Based Biosensor System for Sickle Cell Anemia Mutation. Journal of the Turkish Chemical Society Section A: Chemistry, 9(3), 631-638. https://doi.org/10.18596/jotcsa.1033237
AMA
1.Ertuğrul Uygun HD. Impedimetric CRISPR-dCas9 Based Biosensor System for Sickle Cell Anemia Mutation. JOTCSA. 2022;9(3):631-638. doi:10.18596/jotcsa.1033237
Chicago
Ertuğrul Uygun, Hilmiye Deniz. 2022. “Impedimetric CRISPR-DCas9 Based Biosensor System for Sickle Cell Anemia Mutation”. Journal of the Turkish Chemical Society Section A: Chemistry 9 (3): 631-38. https://doi.org/10.18596/jotcsa.1033237.
EndNote
Ertuğrul Uygun HD (August 1, 2022) Impedimetric CRISPR-dCas9 Based Biosensor System for Sickle Cell Anemia Mutation. Journal of the Turkish Chemical Society Section A: Chemistry 9 3 631–638.
IEEE
[1]H. D. Ertuğrul Uygun, “Impedimetric CRISPR-dCas9 Based Biosensor System for Sickle Cell Anemia Mutation”, JOTCSA, vol. 9, no. 3, pp. 631–638, Aug. 2022, doi: 10.18596/jotcsa.1033237.
ISNAD
Ertuğrul Uygun, Hilmiye Deniz. “Impedimetric CRISPR-DCas9 Based Biosensor System for Sickle Cell Anemia Mutation”. Journal of the Turkish Chemical Society Section A: Chemistry 9/3 (August 1, 2022): 631-638. https://doi.org/10.18596/jotcsa.1033237.
JAMA
1.Ertuğrul Uygun HD. Impedimetric CRISPR-dCas9 Based Biosensor System for Sickle Cell Anemia Mutation. JOTCSA. 2022;9:631–638.
MLA
Ertuğrul Uygun, Hilmiye Deniz. “Impedimetric CRISPR-DCas9 Based Biosensor System for Sickle Cell Anemia Mutation”. Journal of the Turkish Chemical Society Section A: Chemistry, vol. 9, no. 3, Aug. 2022, pp. 631-8, doi:10.18596/jotcsa.1033237.
Vancouver
1.Hilmiye Deniz Ertuğrul Uygun. Impedimetric CRISPR-dCas9 Based Biosensor System for Sickle Cell Anemia Mutation. JOTCSA. 2022 Aug. 1;9(3):631-8. doi:10.18596/jotcsa.1033237

Cited By